Atlas Trials

Alpha/Beta T and CD19+ Depleted Peripheral Stem Cells for Patients With Primary Immunodeficiencies

Clinical trial NCT02990819 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02990819
Sponsor
Children's Hospital of Philadelphia
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
ImmunodeficienciesImmune Dysregulation Syndromes
Start date
2016-12-01
Primary completion
2026-11-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.